Submission of Certificate under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018 for Quarter ended on 31st December, 2025
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Dipna Pharmachem has submitted a compliance certificate to BSE under SEBI Regulation 74(5) for the quarter ended 31 December 2025. The certificate was issued by its Registrar and Share Transfer Agent, Bigshare Services Private Limited. The RTA confirmed that the regulation is not applicable to the company for this quarter, as the entire shareholding of the company is already held in dematerialised (demat) form. Additionally, no requests for dematerialisation or rematerialisation were received from any shareholder during the period 1 October 2025 to 31 December 2025. The letter was signed by Managing Director Keyur Dipakkumar Shah on 7 January 2026.
This is a routine regulatory compliance filing with no material impact on the business, operations, or share price. It merely confirms that all shares are already in demat form, indicating no action is required from shareholders.